-
1 . Academic Journal
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial
- 저자
- by Deville, Jaime G; Carter, Michele F; Mansky, Hannah; Pinto, Jorge A; Ferreira, Flavia F, et al.
- 소스
- In The Lancet HIV May 2022 9(5):e332-e340
-
7 . Periodical
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial
- 저자
- by Ruel, Theodore D; Acosta, Edward P; Liu, Jessica P; Gray, Kathryn P; George, Kathleen, et al.
- 소스
- The Lancet HIV; May 2022, Vol. 9 Issue: 5 pe332-e340, 9p